A randomized trial assessing the immunogenicity and reactogenicity of two hexavalent infant vaccines concomitantly administered with group b meningococcal vaccine by Rajan, M, Marchevsky, N, Sinclair, G, O'Brien, K, Jefferies, K, Owino, N, Hallis, B, Goldblatt, D, Matheson, M, Cuthbertson, H, Aley, P, Snape, MD, Liu, X

Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single-blin... by Costa Clemens, SA, Marchevsky, N, Kelly, S, Felle, S, Eldawi, A, Rajasingam, R, Mahmud, R, Lambe, T, Voysey, M, Gonzalez, I, Milan, EP, Justino, MC, Bibi, S, Aley, P, Clemens, R, Pollard, AJ

Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection by Mentzer, AJ, O'Connor, D, Bibi, S, Chelysheva, I, Clutterbuck, EA, Demissie, T, Dinesh, T, Edwards, NJ, Felle, S, Feng, S, Flaxman, AL, Karp-Tatham, E, Li, G, Liu, X, Marchevsky, N, Godfrey, L, Makinson, R, Bull, MB, Fowler, J, Alamad, B, Malinauskas, T, Chong, AY, Sanders, K, Shaw, RH, Voysey, M, Snape, MD, Pollard, AJ, Lambe, T, Knight, JC

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm sub-study of a phase 2/3 clinical trial by Frater, J, Ewer, K, Ogbe, A, Pace, M, Adele, S, Adland, E, Aley, P, Ali, M, Ansari, M, Bittaye, M, Brown, A, Brown, H, Cappuccini, F, Dejnirattisai, W, Dold, C, Moreira Folegatti, P, Fowler, J, Jenkin, D, Makinson, R, Marchevsky, N, Mujadidi, Y, Parolini, L, Plested, E, Ramasamy, M, Rhead, S, Robinson, H, Robinson, N, Rongkard, P, Tipoe, T, Zacharopoulou, P, Barnes, E, Goulder, P, Klenerman, P, Screaton, G, Hill, A, Gilbert, S, Pollard, AJ, Lambe, T